The shares represent about 5% of Fresenius Medical Care’s issued share capital. Fresenius said the sale will be conducted through an accelerated bookbuilding for institutional investors.
Fresenius Plans to Cut Fresenius Medical Care Stake to 20%
Fresenius plans to sell about 13.4 million shares in Fresenius Medical Care, reducing its stake in the dialysis specialist from 25% to about 20%, the company said Wednesday.
Comments (0)
No comments yet. Be the first!